The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses [version 2; peer review: 2 approved, 1 approved with reservations]

Background: Circulating vaccine derived poliovirus (cVDPV) outbreaks remain a threat to polio eradication. To reduce cases of polio from cVDPV of serotype 2, the serotype 2 component of the vaccine has been removed from the global vaccine supply, but outbreaks of cVDPV2 have continued. The objective...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Gates Open Research
المؤلفون الرئيسيون:	Megan Auzenbergs, Grace Macklin, Holly Fountain, Kathleen M O'Reilly, Hil Lyons
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	F1000 Research Ltd 2022-05-01
الموضوعات:	polio vaccination eradication cVDPVs OPV eng
الوصول للمادة أونلاين:	https://gatesopenresearch.org/articles/5-94/v2

مواد مشابهة

The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses [version 1; peer review: 2 approved, 1 approved with reservations]
حسب: Megan Auzenbergs, وآخرون
منشور في: (2021-06-01)

The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses [version 3; peer review: 2 approved, 1 approved with reservations]
حسب: Megan Auzenbergs, وآخرون
منشور في: (2023-04-01)

Complexity of options related to restarting oral poliovirus vaccine (OPV) in national immunization programs after OPV cessation [version 1; peer review: 1 approved, 2 approved with reservations]
حسب: Steven GF Wassilak, وآخرون
منشور في: (2023-04-01)

Increasing Population Immunity Prior to Globally-Coordinated Cessation of Bivalent Oral Poliovirus Vaccine (bOPV)
حسب: Nima D. Badizadegan, وآخرون
منشور في: (2024-09-01)

Detection of vaccine-derived poliovirus type-3 in sewage of Kathmandu Valley, Nepal
حسب: Rachana Mehta, وآخرون
منشور في: (2024-11-01)

Metagenomic sequencing, molecular characterization, and Bayesian phylogenetics of imported type 2 vaccine-derived poliovirus, Spain, 2021
حسب: Maria Dolores Fernandez-Garcia, وآخرون
منشور في: (2023-05-01)

Eradication of wild poliovirus in Nigeria: Lessons learnt
حسب: Osmond C. Ekwebelem, وآخرون
منشور في: (2021-11-01)

Review of Poliovirus Transmission and Economic Modeling to Support Global Polio Eradication: 2020–2024
حسب: Kimberly M. Thompson, وآخرون
منشور في: (2024-05-01)

Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India
حسب: Madhu Chhanda Mohanty, وآخرون
منشور في: (2017-10-01)

Securing the Future: Strategies for Global Polio Vaccine Security Amid Eradication Efforts
حسب: Vachagan Harutyunyan, وآخرون
منشور في: (2024-12-01)

Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine
حسب: Radboud J. Duintjer Tebbens, وآخرون
منشور في: (2018-08-01)

Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in Panama
حسب: Magda Rojas-Bonilla, وآخرون
منشور في: (2021-07-01)

Perbandingan Manfaat Vaksin Oral Polio 1 (Monovalen) dengan Vaksin Oral Polio Trivalen Terhadap Transmisi Virus Polio 1 dalam Upaya Mengatasi Kejadian Luar Biasa Polio 1 di Indonesia Tahun 2005: ditinjau melalui respons imun dan keamanannya
حسب: Kusnandi Rusmil
منشور في: (2016-11-01)

Epidemiological Surveillance of Acute Flaccid Paralysis for Eradication of Poliomyelitis (A Brief Review)
حسب: Simeonova I., وآخرون
منشور في: (2024-03-01)

Modeling undetected poliovirus circulation following the 2022 outbreak in the United States
حسب: Dominika A. Kalkowska, وآخرون
منشور في: (2024-12-01)

Logistical challenges and assumptions for modeling the failure of global cessation of oral poliovirus vaccine (OPV)
حسب: Kimberly M. Thompson, وآخرون
منشور في: (2019-07-01)

Quantitative RT-PCR Assays for Quantification of Undesirable Mutants in the Novel Type 2 Oral Poliovirus Vaccine
حسب: Hasmik Manukyan, وآخرون
منشور في: (2022-08-01)

Eradikasi Polio
حسب: Hindra Irawan Satari, وآخرون
منشور في: (2017-01-01)

Poliovirus vaccination during the endgame: insights from integrated modeling
حسب: Radboud J. Duintjer Tebbens, وآخرون
منشور في: (2017-06-01)

Looking back at prospective modeling of outbreak response strategies for managing global type 2 oral poliovirus vaccine (OPV2) cessation
حسب: Kimberly M. Thompson, وآخرون
منشور في: (2023-03-01)

Does IPV Boost Intestinal Immunity among Children under Five Years of Age? An Experience from Pakistan
حسب: Muhammad Atif Habib, وآخرون
منشور في: (2023-09-01)

Monitoring the Risk of Type-2 Circulating Vaccine-Derived Poliovirus Emergence During Roll-Out of Type-2 Novel Oral Polio Vaccine
حسب: Corey M. Peak, وآخرون
منشور في: (2024-11-01)

Lessons from Vaccine-Related Poliovirus in Israel, UK and USA
حسب: T. Jacob John, وآخرون
منشور في: (2022-11-01)

Development of RT-PCR Assays for Simple Detection and Identification of Sabin Virus Contaminants in the Novel Oral Poliovirus Vaccines
حسب: Olga Singh, وآخرون
منشور في: (2025-01-01)

Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use
حسب: Radboud J. Duintjer Tebbens, وآخرون
منشور في: (2018-04-01)

Development of a Quantitative One-Step RT-PCR Method for the Detection of Sabin 2 Virus Contamination in a Novel Oral Poliovirus Vaccine Type 2
حسب: Hasmik Manukyan, وآخرون
منشور في: (2021-06-01)

Environmental Surveillance for Polioviruses in Haïti (2017–2019): The Dynamic Process for the Establishment and Monitoring of Sampling Sites
حسب: Mary M. Alleman, وآخرون
منشور في: (2021-03-01)

Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine
حسب: Jiawei Xu, وآخرون
منشور في: (2024-05-01)

Monitoring the VDPV2 outbreak in Egypt during 2020–2021 highlights the crucial role of environmental surveillance and boosting immunization in combating Poliovirus
حسب: Menna R. Shabana, وآخرون
منشور في: (2024-08-01)

Vaccine-Derived Polioviruses Not Detected by Global Surveillance Screening Assay
حسب: Deepa K. Sharma, وآخرون
منشور في: (2015-10-01)

ACUTE FLACCID PARALYSIS REGISTERED FOR THE PERIOD 2012-2020, IN STARA ZAGORA REGION
حسب: I. Simeonova, وآخرون
منشور في: (2021-06-01)

Communicable Episode 18: The Nightmare Series, part 4 – rubella & polio
حسب: Kathryn Hostettler, وآخرون
منشور في: (2025-06-01)

Application of MPBT Assay for Multiplex Determination of Infectious Titers and for Selection of the Optimal Formulation for the Trivalent Novel Oral Poliovirus Vaccine
حسب: Hasmik Manukyan, وآخرون
منشور في: (2024-06-01)

The Molecular Evolution of Type 2 Vaccine-Derived Polioviruses in Individuals with Primary Immunodeficiency Diseases
حسب: Kouichi Kitamura, وآخرون
منشور في: (2021-07-01)

Reproductive and Mortality Outcomes in Wistar Rats Following Oral Polio Vaccine Administration
حسب: Ibrahim Baffa Musa Anda, وآخرون
منشور في: (2025-06-01)

Culture-Independent Detection of Poliovirus in Stool Samples by Direct RNA Extraction
حسب: Chelsea Harrington, وآخرون
منشور في: (2021-12-01)

Assessment of Enterovirus Excretion and Identification of VDPVs in Patients with Primary Immunodeficiency in India: Outcome of ICMR–WHO Collaborative Study Phase-I
حسب: Madhu Chhanda Mohanty, وآخرون
منشور في: (2023-07-01)

A journey worth taking: global eradication of measles, rubella and congenital rubella syndrome
حسب: Jon Kim Andrus, وآخرون
منشور في: (2025-12-01)

Oral polio vaccine stockpile modeling: insights from recent experience
حسب: Kimberly M. Thompson, وآخرون
منشور في: (2023-12-01)

Polio eradication in Pakistan: Hope against hope or are we near eradication?
حسب: Tauseef Ahmad, وآخرون
منشور في: (2024-03-01)